{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:53:45Z","timestamp":1718639625880},"reference-count":145,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.vph.2006.01.017","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T19:09:34Z","timestamp":1152212974000},"page":"36-45","source":"Crossref","is-referenced-by-count":11,"title":["The complex role of PPAR\u03b3 in renal dysfunction in obesity: Managing a Janus-faced receptor"],"prefix":"10.1016","volume":"45","author":[{"given":"Anca Dana","family":"Dobrian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00416.x","article-title":"A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.ASN.0000042167.66685.EA","article-title":"Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma","volume":"14","author":"Arici","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-4889(00)00054-9","article-title":"Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation","volume":"1497","author":"Asano","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.vph.2006.01.017_bib4","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1097\/01.ASN.0000141965.28037.EE","article-title":"Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?","volume":"15","author":"Bagby","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6764","key":"10.1016\/j.vph.2006.01.017_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/jpet.103.055616","article-title":"Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity","volume":"307","author":"Baylis","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl 11","key":"10.1016\/j.vph.2006.01.017_bib7","first-page":"S225","article-title":"Angiotensin II stimulates macula densa basolateral sodium\/hydrogen exchange via type 1 angiotensin II receptors","volume":"10","author":"Bell","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/15209150260007381","article-title":"Physiological and therapeutic roles of peroxisome proliferator-activated receptors","volume":"4","author":"Berger","year":"2002","journal-title":"Diabetes Technol. Ther."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib9","doi-asserted-by":"crossref","first-page":"F639","DOI":"10.1152\/ajprenal.2001.281.4.F639","article-title":"Increased renal Na\u2013K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats","volume":"281","author":"Bickel","year":"2001","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib10","first-page":"F758","article-title":"Thromboxane A2 contributes to the enhanced tubuloglomerular feedback activity in young SHR","volume":"276","author":"Brannstrom","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diabetes.47.8.1326","article-title":"Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats","volume":"47","author":"Buckingham","year":"1998","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.ATV.0000044461.01844.C9","article-title":"Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells","volume":"23","author":"Calnek","year":"2003","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.vph.2006.01.017_bib13","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/01.ASN.0000025786.87646.B1","article-title":"PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines","volume":"13","author":"Cernuda-Morollon","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib14","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","author":"Chagnac","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib15","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/j.1523-1755.2004.00602.x","article-title":"Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway","volume":"65","author":"Chang","year":"2004","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.104.074088","article-title":"GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats","volume":"312","author":"Chen","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1345\/aph.1D400","article-title":"Thiazolidinedione-induced congestive heart failure","volume":"38","author":"Cheng","year":"2004","journal-title":"Ann. Pharmacother."},{"issue":"4 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib18","first-page":"F601","article-title":"Time course of proximal tubule response to acute arterial hypertension in the rat","volume":"254","author":"Chou","year":"1988","journal-title":"Am. J. Physiol."},{"issue":"19","key":"10.1016\/j.vph.2006.01.017_bib19","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1074\/jbc.M100878200","article-title":"Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists","volume":"2076","author":"Davies","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1172\/JCI118860","article-title":"Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma","volume":"98","author":"De Vos","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/oby.2004.162","article-title":"Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria","volume":"12","author":"Dey","year":"2004","journal-title":"Obes. Res."},{"issue":"19","key":"10.1016\/j.vph.2006.01.017_bib22","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000016049.86468.23","article-title":"Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma","volume":"105","author":"Diep","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.HYP.35.4.1009","article-title":"Development of hypertension in a rat model of diet-induced obesity","volume":"35","author":"Dobrian","year":"2000","journal-title":"Hypertension"},{"issue":"2 Part 2","key":"10.1016\/j.vph.2006.01.017_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/01.HYP.37.2.554","article-title":"Oxidative stress in a rat model of obesity-induced hypertension","volume":"37","author":"Dobrian","year":"2001","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib25","first-page":"387a","article-title":"Insulin sensitizers normalize blood pressure in a rat model of diet-induced obesity","volume":"40","author":"Dobrian","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2006.01.017_bib26","article-title":"PPARg activation prevents hypertension and reduces oxidative stress in diet-induced obesity","author":"Dobrian","year":"2002","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.HYP.0000103629.01745.59","article-title":"Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity","volume":"43","author":"Dobrian","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib28","first-page":"395a","article-title":"Reduced renal PPARgamma activity induces increased tubular sodium reabsorption and hypertension in a rat model of diet-induced obesity","volume":"42","author":"Dobrian","year":"2003","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","article-title":"Physiology and pathophysiology of the adipose tissue renin\u2013angiotensin system","volume":"35","author":"Engeli","year":"2000","journal-title":"Hypertension"},{"issue":"30","key":"10.1016\/j.vph.2006.01.017_bib30","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2006.01.017_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1749-6632.1996.tb18621.x","article-title":"The peroxisome proliferator-activated receptors: ligands and activators","volume":"0804","author":"Forman","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"17","key":"10.1016\/j.vph.2006.01.017_bib32","doi-asserted-by":"crossref","first-page":"17118","DOI":"10.1074\/jbc.M407539200","article-title":"A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome","volume":"280","author":"Freedman","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3\u20134","key":"10.1016\/j.vph.2006.01.017_bib33","first-page":"469","article-title":"Glomerular endothelial cytotoxicity and dysfunction in nephrosis with focal segmental glomerulosclerosis","volume":"29","author":"Futrakul","year":"2003","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.HYP.36.3.430","article-title":"Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects","volume":"36","author":"Garg","year":"2000","journal-title":"Hypertension"},{"issue":"3 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib35","first-page":"F377","article-title":"Nitric oxide inhibits sodium\/hydrogen exchange activity in the thick ascending limb","volume":"277","author":"Garvin","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib36","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1046\/j.1523-1755.1999.00456.x","article-title":"Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers","volume":"55","author":"Glynne","year":"1999","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.vph.2006.01.017_bib37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/00004872-200309000-00027","article-title":"Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study","volume":"21","author":"Grassi","year":"2003","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption","volume":"11","author":"Guan","year":"2005","journal-title":"Nat. Med."},{"issue":"6 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib39","first-page":"F1013","article-title":"Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans","volume":"273","author":"Guan","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib40","doi-asserted-by":"crossref","first-page":"F1036","DOI":"10.1152\/ajprenal.0025.2001","article-title":"Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature","volume":"281","author":"Guan","year":"2001","journal-title":"Am. J. Physiol., Renal Physiol."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/diabetes.53.1.200","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells","volume":"53","author":"Guo","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.arrt.2003.10.007","article-title":"Is obesity a major cause of chronic kidney disease?","volume":"11","author":"Hall","year":"2004","journal-title":"Adv. Renal Replace Ther."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11906-003-0084-z","article-title":"Impact of the obesity epidemic on hypertension and renal disease","volume":"5","author":"Hall","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"issue":"5 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib44","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension","volume":"10","author":"Hall","year":"1997","journal-title":"Am. J. Hypertens."},{"issue":"3 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000052314.95497.78","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"issue":"1 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib46","first-page":"F170","article-title":"Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody","volume":"273","author":"Harrison-Bernard","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.33.4.943","article-title":"Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells","volume":"33","author":"Hattori","year":"1999","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1681.1998.tb02147.x","article-title":"Cardiovascular consequences of obesity: role of leptin","volume":"25","author":"Haynes","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.HYP.30.3.619","article-title":"Sympathetic and cardiorenal actions of leptin","volume":"30","author":"Haynes","year":"1997","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib50","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1074\/jbc.272.8.5283","article-title":"Functional antagonism between CCAAT\/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter","volume":"272","author":"Hollenberg","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.vph.2006.01.017_bib51","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1096\/fj.03-0181fje","article-title":"PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells","volume":"17","author":"Hong","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib52","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"5091","key":"10.1016\/j.vph.2006.01.017_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-128-2-199801150-00001","article-title":"Body weight, weight change, and risk for hypertension in women","volume":"128","author":"Huang","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1081\/CEH-100107389","article-title":"Dopamine fails to inhibit Na, H-exchanger in proximal tubules of obese Zucker rats","volume":"23","author":"Hussain","year":"2001","journal-title":"Clin. Exp. Hypertens."},{"issue":"1\u20132","key":"10.1016\/j.vph.2006.01.017_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10641969909068646","article-title":"Renal dopamine receptor signaling mechanisms in spontaneously hypertensive and Fischer 344 old rats","volume":"21","author":"Hussain","year":"1999","journal-title":"Clin. Exp. Hypertens."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/153537020322800202","article-title":"Renal dopamine receptors and hypertension","volume":"228","author":"Hussain","year":"2003","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib58","doi-asserted-by":"crossref","first-page":"C899","DOI":"10.1152\/ajpcell.00474.2004","article-title":"Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production","volume":"288","author":"Hwang","year":"2005","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.ATV.0000047447.67827.CD","article-title":"Effect of peroxisome proliferator-activated receptor-alpha and-gamma activators on vascular remodeling in endothelin-dependent hypertension","volume":"23","author":"Iglarz","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib60","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.HYP.35.6.1232","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells","volume":"35","author":"Ikeda","year":"2000","journal-title":"Hypertension"},{"issue":"42","key":"10.1016\/j.vph.2006.01.017_bib61","doi-asserted-by":"crossref","first-page":"33142","DOI":"10.1074\/jbc.M002319200","article-title":"Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2","volume":"275","author":"Ikeda","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.vph.2006.01.017_bib62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib63","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/med.1025","article-title":"Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond","volume":"21","author":"Jones","year":"2001","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.ijo.0801846","article-title":"Associations between weight gain and incident hypertension in a bi-ethnic cohort: the atherosclerosis risk in communities study","volume":"26","author":"Stevens","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib65","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib66","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1523-1755.2002.00618.x","article-title":"Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage","volume":"62","author":"Kamijo","year":"2002","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","article-title":"The relation of adiposity to blood pressure and development of hypertension. The Framingham study","volume":"67","author":"Kannel","year":"1967","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.vph.2006.01.017_bib68","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4065\/78.9.1088","article-title":"Thiazolidinedione-associated congestive heart failure and pulmonary edema","volume":"78","author":"Kermani","year":"2003","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib69","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/j.1523-1755.2005.00320.x","article-title":"Renal cyclooxygenase-2 in obese Zucker (fatty) rats","volume":"67","author":"Komers","year":"2005","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1152\/ajprenal.00129.2001","article-title":"Angiotensin II directly stimulates macula densa Na\u20132Cl\u2013K cotransport via apical AT(1) receptors","volume":"282","author":"Kovacs","year":"2002","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-3476(99)70401-4","article-title":"Relative antioxidant deficiency in obese children: a weighty contributor to morbidity?","volume":"134","author":"Lavine","year":"1999","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1210\/jc.86.1.280","article-title":"Rosiglitazone monotherapy is effective in patients with type 2 diabetes","volume":"86","author":"Lebovitz","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.vph.2006.01.017_bib73","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.metabol.2005.04.015","article-title":"The effects of thiazolidinedione treatment on the regulations of aquaglyceroporins and glycerol kinase in OLETF rats","volume":"54","author":"Lee","year":"2005","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib74","doi-asserted-by":"crossref","first-page":"F1111","DOI":"10.1152\/ajprenal.00218.2001","article-title":"Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney","volume":"282","author":"Li","year":"2002","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1755.1999.00583.x","article-title":"Nitric oxide reduces the molecular activity of Na+, K+-ATPase in opossum kidney cells","volume":"56","author":"Liang","year":"1999","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib76","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.2001.281.3.F414","article-title":"Mechanism underlying diuretic effect of l-NAME at a subpressor dose","volume":"281","author":"Liang","year":"2001","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib77","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats","volume":"59","author":"Ma","year":"2001","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib78","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cellbi.2005.01.005","article-title":"Pioglitazone attenuates TGF-beta(1)-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma","volume":"29","author":"Maeda","year":"2005","journal-title":"Cell Biol. Int."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/1056-8727(95)80022-7","article-title":"Phenotypic changes of the mesangium in diabetic nephropathy","volume":"9","author":"Makino","year":"1995","journal-title":"J. Diabetes Complicat."},{"issue":"2 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/hy0202.103469","article-title":"Increased renal medullary oxidative stress produces hypertension","volume":"39","author":"Makino","year":"2002","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib81","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib82","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1046\/j.1523-1755.2000.00418.x","article-title":"Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion","volume":"58","author":"McCarthy","year":"2000","journal-title":"Kidney Int."},{"issue":"24","key":"10.1016\/j.vph.2006.01.017_bib83","doi-asserted-by":"crossref","first-page":"16973","DOI":"10.1074\/jbc.274.24.16973","article-title":"SGK is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial Na+ channels","volume":"274","author":"Naray-Fejes-Toth","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am. J. Kidney Dis."},{"issue":"2 Part 2","key":"10.1016\/j.vph.2006.01.017_bib85","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.HYP.37.2.722","article-title":"Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells","volume":"37","author":"Nicholas","year":"2001","journal-title":"Hypertension"},{"issue":"4 Pt 1","key":"10.1016\/j.vph.2006.01.017_bib86","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjhyper.2004.10.032","article-title":"PPARgamma in endothelial cells influences high fat diet-induced hypertension","volume":"18","author":"Nicol","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0895-7061(95)96214-5","article-title":"Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives","volume":"8","author":"Ogihara","year":"1995","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib88","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2004.02.175","article-title":"Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione","volume":"317","author":"Onozaki","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib89","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/hy09t1.093361","article-title":"Intrarenal transport and vasoactive substances in hypertension","volume":"38","author":"Ortiz","year":"2001","journal-title":"Hypertension"},{"issue":"2 Part 2","key":"10.1016\/j.vph.2006.01.017_bib90","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.37.2.467","article-title":"NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase","volume":"37","author":"Ortiz","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib91","doi-asserted-by":"crossref","first-page":"F777","DOI":"10.1152\/ajprenal.00334.2001","article-title":"Role of nitric oxide in the regulation of nephron transport","volume":"282","author":"Ortiz","year":"2002","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"11 Pt 1","key":"10.1016\/j.vph.2006.01.017_bib92","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib93","doi-asserted-by":"crossref","first-page":"F528","DOI":"10.1152\/ajprenal.00445.2003","article-title":"The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells","volume":"287","author":"Panchapakesan","year":"2004","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib94","doi-asserted-by":"crossref","first-page":"F1153","DOI":"10.1152\/ajprenal.00097.2005","article-title":"PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose","volume":"289","author":"Panchapakesan","year":"2005","journal-title":"Am. J. Physiol., Renal. Physiol."},{"key":"10.1016\/j.vph.2006.01.017_bib95","article-title":"Compartment-Specific Expression and Function of the Chemokine IP-10\/CXCL10 in a Model of Renal Endothelial Microvascular Injury","author":"Panzer","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/diabetes.50.1.159","article-title":"Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C","volume":"50","author":"Perticone","year":"2001","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib97","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1046\/j.1523-1755.1998.00200.x","article-title":"Regulation of macula densa Na:H exchange by angiotensin II","volume":"54","author":"Peti-Peterdi","year":"1998","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/15.4.467","article-title":"Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats","volume":"15","author":"Poirier","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.vph.2006.01.017_bib99","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000177805.65864.d4","article-title":"Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms","volume":"25","author":"Polikandriotis","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11\u201312","key":"10.1016\/j.vph.2006.01.017_bib100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1515\/CCLM.1999.164","article-title":"Plasma malondialdehyde and obesity: is there a relationship?","volume":"37","author":"Prazny","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5 Pt 1","key":"10.1016\/j.vph.2006.01.017_bib101","first-page":"L699","article-title":"The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide [see comments]","volume":"268","author":"Pryor","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"14","key":"10.1016\/j.vph.2006.01.017_bib102","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1523\/JNEUROSCI.23-14-05998.2003","article-title":"Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin","volume":"23","author":"Rahmouni","year":"2003","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.vph.2006.01.017_bib103","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.54.7.2012","article-title":"Role of selective leptin resistance in diet-induced obesity hypertension","volume":"54","author":"Rahmouni","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib104","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/clim.2000.4985","article-title":"Prostaglandin J(2) inhibition of mesangial cell iNOS expression","volume":"98","author":"Reilly","year":"2001","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.HYP.36.3.423","article-title":"Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet","volume":"36","author":"Roberts","year":"2000","journal-title":"Hypertension"},{"issue":"1 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib106","first-page":"F106","article-title":"Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule","volume":"270","author":"Roczniak","year":"1996","journal-title":"Am J Physiol"},{"issue":"9","key":"10.1016\/j.vph.2006.01.017_bib107","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00004872-199816090-00007","article-title":"Anti-oxidant status and lipid peroxidation in patients with essential hypertension","volume":"16","author":"Russo","year":"1998","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib108","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.HYP.0000116303.71408.c2","article-title":"PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice","volume":"43","author":"Ryan","year":"2004","journal-title":"Hypertension"},{"issue":"1\u20132","key":"10.1016\/j.vph.2006.01.017_bib109","first-page":"103","article-title":"Oxygen free radicals in essential hypertension","volume":"111","author":"Sagar","year":"1992","journal-title":"Mol. Cell. Biochem."},{"issue":"9 Pt 1","key":"10.1016\/j.vph.2006.01.017_bib110","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0895-7061(97)00160-X","article-title":"Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits","volume":"10","author":"Saku","year":"1997","journal-title":"Am. J. Hypertens."},{"issue":"6549","key":"10.1016\/j.vph.2006.01.017_bib111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/377527a0","article-title":"Transient increase in obese gene expression after food intake or insulin administration","volume":"377","author":"Saladin","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1291\/hypres.27.417","article-title":"Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney","volume":"27","author":"Sato","year":"2004","journal-title":"Hypertens. Res."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib113","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib114","doi-asserted-by":"crossref","first-page":"F302","DOI":"10.1152\/ajprenal.2000.279.2.F302","article-title":"TP receptor-mediated vasoconstriction in microperfused afferent arterioles: roles of O(2)(-) and NO","volume":"279","author":"Schnackenberg","year":"2000","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1463-1326.2000.00099.x","article-title":"Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat","volume":"2","author":"Smith","year":"2000","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib116","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/jpet.103.058008","article-title":"Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats","volume":"308","author":"Song","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib117","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1464-5491.2004.01274.x","article-title":"Thiazolidinediones and congestive heart failure-exacerbation or new onset of left ventricular dysfunction?","volume":"21","author":"Srivastava","year":"2004","journal-title":"Diabet. Med."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1291\/hypres.24.229","article-title":"Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes","volume":"24","author":"Sugawara","year":"2001","journal-title":"Hypertens. Res."},{"issue":"7","key":"10.1016\/j.vph.2006.01.017_bib119","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1210\/en.142.7.3125","article-title":"Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells","volume":"142","author":"Sugawara","year":"2001","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.vph.2006.01.017_bib120","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1074\/jbc.M104560200","article-title":"Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells","volume":"277","author":"Sugawara","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.vph.2006.01.017_bib121","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.102.15.1834","article-title":"Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"102","author":"Takeda","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.vph.2006.01.017_bib122","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0735-1097(03)00159-1","article-title":"Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure","volume":"41","author":"Tang","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.vph.2006.01.017_bib123","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","article-title":"Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia","volume":"108","author":"Tao","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib124","doi-asserted-by":"crossref","first-page":"C541","DOI":"10.1152\/ajpcell.2000.279.3.C541","article-title":"Mechanisms of sodium pump regulation","volume":"279","author":"Therien","year":"2000","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib125","doi-asserted-by":"crossref","first-page":"F640","DOI":"10.1152\/ajprenal.00001.2002","article-title":"Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria","volume":"283","author":"Thomas","year":"2002","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"6 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib126","first-page":"F1177","article-title":"Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line","volume":"268","author":"Thomas","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib127","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000168653","article-title":"Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin","volume":"13","author":"Thomas","year":"1993","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib128","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.00362.2004","article-title":"Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats","volume":"289","author":"Trivedi","year":"2005","journal-title":"Am. J. Physiol., Renal. Physiol."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.HYP.0000111587.51185.fe","article-title":"Rosiglitazone restores G-protein coupling, recruitment, and function of renal dopamine D1A receptor in obese Zucker rats","volume":"43","author":"Trivedi","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0024-3205(97)00403-7","article-title":"Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.vph.2006.01.017_bib131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0895-7061(97)00053-8","article-title":"Plasma angiotensinogen concentrations in obese patients","volume":"10","author":"Umemura","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2006.01.017_bib132","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0021-9150(97)00316-X","article-title":"The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects","volume":"137 Suppl","author":"Van Gaal","year":"1998","journal-title":"Atherosclerosis"},{"issue":"Suppl 3","key":"10.1016\/j.vph.2006.01.017_bib133","first-page":"S21","article-title":"Human obesity: from lipid abnormalities to lipid oxidation","volume":"19","author":"Van Gaal","year":"1995","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib134","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000079865","article-title":"Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake","volume":"27","author":"Vaneckova","year":"2004","journal-title":"Kidney Blood Press. Res."},{"issue":"7","key":"10.1016\/j.vph.2006.01.017_bib135","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diabetes.48.7.1448","article-title":"The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats","volume":"48","author":"Walker","year":"1999","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib136","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/152091502760306599","article-title":"Management of rosiglitazone-induced edema: two case reports and a review of the literature","volume":"4","author":"Wang","year":"2002","journal-title":"Diabetes Technol. Ther."},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000183467","article-title":"Massive obesity and nephrotic proteinuria with a normal renal biopsy","volume":"40","author":"Wesson","year":"1985","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.vph.2006.01.017_bib138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11906-002-0041-2","article-title":"Reactive oxygen species: roles in blood pressure and kidney function","volume":"4","author":"Wilcox","year":"2002","journal-title":"Curr. Hypertens. Rep."},{"issue":"6 Pt 2","key":"10.1016\/j.vph.2006.01.017_bib139","first-page":"F966","article-title":"Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney","volume":"277","author":"Yang","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"6 Pt 1","key":"10.1016\/j.vph.2006.01.017_bib140","first-page":"E989","article-title":"Antihypertensive and vasculo-and renoprotective effects of pioglitazone in genetically obese diabetic rats","volume":"272","author":"Yoshimoto","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.vph.2006.01.017_bib141","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1523-1755.2004.00574.x","article-title":"Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses","volume":"65","author":"Zafiriou","year":"2004","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.vph.2006.01.017_bib142","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.2004040278","article-title":"Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts","volume":"16","author":"Zafiriou","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"26","key":"10.1016\/j.vph.2006.01.017_bib143","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0501744102","article-title":"Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.vph.2006.01.017_bib144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.HYP.24.1.106","article-title":"Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity","volume":"24","author":"Zhang","year":"1994","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.vph.2006.01.017_bib145","doi-asserted-by":"crossref","first-page":"F639","DOI":"10.1152\/ajprenal.00189.2001","article-title":"Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation","volume":"282","author":"Zheng","year":"2002","journal-title":"Am. J. Physiol., Renal. Physiol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718910600084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718910600084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T17:41:45Z","timestamp":1555695705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718910600084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S153718910600084X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2006.01.017","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}